Capital expenditure · 2015–2023

Ascendis Pharma capital expenditure

$2.6M−82.7% · FY2023

Ascendis Pharma (ASND) reported $2.6M in capital expenditure for fiscal 2023, −82.7% year on year.

$1.2M2015$743,8392016$1.1M2017$3.1M2018$5.8M2019$22.7M2020$28.0M2021$15.3M2022$2.6M2023
Ascendis Pharma — Capital expenditure, 2015–2023
Fiscal yearCapital expenditureChangeFiling
FY20232023-12-31$2.6M−82.7%Open →
FY20222022-12-31$15.3M−45.6%Open →
FY20212021-12-31$28.0M+23.6%Open →
FY20202020-12-31$22.7M+292.8%Open →
FY20192019-12-31$5.8M+84.7%Open →
FY20182018-12-31$3.1M+194.2%Open →
FY20172017-12-31$1.1M+42.9%Open →
FY20162016-12-31$743,839−35.5%Open →
FY20152015-12-31$1.2M—Open →

Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2023 compound annual growth +10.9%

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

Capital expenditure at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Ascendis Pharma capital expenditure |url=https://companiesranked.com/en/company/ascendis-pharma/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Ascendis Pharma capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/capital-expenditure

BibTeX

@misc{companiesranked-en-company-ascendis-pharma-capital-expenditure-2026,
  author       = {{CompaniesRanked}},
  title        = {{Ascendis Pharma capital expenditure}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/capital-expenditure}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0000950170-24-012212 · February 7, 2024

{{cite web |title=Ascendis Pharma capital expenditure — 20-F (0000950170-24-012212) |url=https://www.sec.gov/Archives/edgar/data/1612042/000095017024012212/asnd-20231231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2024-02-07}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Ascendis Pharma overview